Crocetin (Toronto Research Chemicals, North York, ON, Canada) was dissolved in DMSO (AppliChem, Darmstadt, Germany) to a concentration of 90 mM and kept at -20 °C. For experiments, the stock solution was diluted with culture medium to a final concentration of 1, 10, 50, 100, or 200 µM crocetin, also diluting DMSO to a safe range (0.1–0.2%, i.e., < 0.5% (v/v)). Cells were exposed to crocetin for different incubation times including: (i) for 24 h before exposure to TBHP (pre-treatment), (ii) and/or for 4 h with TBHP (co-treatment), (iii) and/or for 12 h after exposure to TBHP (post-treatment). Ascorbic acid (vitamin C) (Sigma–Aldrich, Taufkirchen, Germany) was dissolved in water and then diluted in culture medium to a concentration of 100 µM. DL-α-tocopherol acetate (vitamin E) (Sigma–Aldrich, Taufkirchen, Germany) was diluted in water to a concentration of 10 mM, then diluted in culture medium to a concentration of 100 µM.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.